RoslinCT is a contract manufacturing organisation focused on providing tailored process development services and robust GMP manufacturing solutions for companies developing cell-based therapeutics for clinical trials.
Supporting you at every step of your advanced therapy journey.
26 March 2019
RoslinCT is a leading Contract Development and Manufacturing Organisation (CDMO), offering a range of integrated services from technology transfer, process and assay development through to GMP manufacturing, storage, QP certification and batch release of cell-based therapies for clinical trials.
22 March 2019
RoslinCT, a leading cell and gene therapy contract manufacturing organisation, is pleased to announce the appointment of David Bowie to the Board of Directors. David has over twenty-eight years of international sales, marketing management and business development experience in the global healthcare sector which led him to the board of the Scottish Government backed Life Science Scotland Industry Leadership Group for some 12 years. David brings a wealth of life science industry experience, locally and globally, to the position.
18 October 2018
RoslinCT, a leading cell and gene therapy contract manufacturing organisation, is delighted to announce the appointment of Ian McCubbin OBE to the Board of Directors. Ian is a prominent figure within the Advanced Therapy community and brings a wealth of industry experience to the position
10:01 am Feb 11th
We are so proud of all the inspiring women at RoslinCT and we are grateful for the expertise and quality they bring… https://t.co/TBf54ehcwU
09:45 am Feb 5th
[Infographic] We can’t believe that the first month of 2020 is already over! Reflecting back, 2019 was a great year… https://t.co/J0aLOCJA9h
03:02 pm Jan 15th